Skip to main content

Renal Vasculitis in Children

  • Chapter
  • First Online:
Pediatric Kidney Disease

Abstract

In this chapter, we focus on antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and glomerulonephritis (GN) as a prototype of “renal vasculitis” in children. Vasculitis is a clinical and pathological “merged” entity that has undergone substantial changes during the past decades; this has created some confusion in understanding it. In particular, several changes in the concept and terminology of vasculitis and the classical clinical entity of rapidly progressive glomerulonephritis (RPGN) have caused confusion in the diagnosis of vasculitis and ANCA-associated GN. The differences in perspectives among nephrologists, rheumatologists, and pathologists have exacerbated the confusion as well. Therefore, we have tried to arrange these perspectives so as to be simple. We will review the recent genome-wide association analysis, which has revealed the genetic difference between granulomatosis with polyangiitis and microscopic polyangiitis, as well as discuss the roles of ANCA itself, human lysosomal membrane protein-2 (hLAMP-2) and neutrophil extracellular traps (NETs) in the pathogenesis of ANCA-associated glomerulonephritis. Recent therapies and the prognosis of ANCA-associated glomerulonephritis are also illustrated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AAGN:

ANCA-associated glomerulonephritis

AAV:

ANCA-associated vasculitis

ANCA:

Antineutrophil cytoplasmic antibody

CPA:

Oral cyclophosphamide

EGP:

Eosinophilic granuloma with polyangiitis (Churg-Strauss syndrome)

ENT:

Ear nose, and throat

GBM:

Glomerular basement membrane

GN:

Glomerulonephritis

GPA:

Granulomatous polyangiitis (WG)

HSPN:

Henoch-Schönlein purpura nephritis

LAMP-2:

Lysosome-associated membrane protein-2

MHC:

Major histocompatibility complex

MMI:

Methimazole

MPA:

Microscopic polyangiitis

MPO:

Myeloperoxidase

NCGN:

Necrotizing crescentic glomerulonephritis

NETs:

Neutrophil extracellular traps

PAN:

Polyarteritis nodosa

PE:

Plasma exchange

PR3:

Proteinase-3

PTU:

Propylthiouracil

RLV:

Renal-limited vasculitis

RPGN:

Rapidly progressive glomerulonephritis

SNP:

Single nucleotide polymorphism

SOV:

Single-organ vasculitis

VVV:

Variable vessel vasculitis

WG:

Wegener’s granulomatosis (GPA)

References

  1. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164–77.

    Article  PubMed  Google Scholar 

  2. Bell ET. A clinical and pathological study of subacute and chronic glomerulonephritis, including lipoid nephrosis. Am J Pathol. 1938;14(6):691–736.5.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Ellis A. Natural history of Bright’s disease. Clinical, histological and experimental observations. Lancet. 1942;239(6176):34–6.

    Article  Google Scholar 

  4. Duncan DA, Drummond KN, Michael AF, Vernier RL. Pulmonary hemorrhage and glomerulonephritis. Report of six cases and study of the renal lesion by the fluorescent antibody technique and electron microscopy. Ann Intern Med. 1965;62:920–38.

    Article  CAS  PubMed  Google Scholar 

  5. Sturgill BC, Westervelt FB. Immunofluorescence studies in a case of Goodpasture’s syndrome. JAMA. 1965;194(8):914–6.

    Article  CAS  PubMed  Google Scholar 

  6. Bacani RA, Velasquez F, Kanter A, Pirani CL, Pollak VE. Rapidly progressive (nonstreptococcal) glomerulonephritis. Ann Intern Med. 1968;69(3):463–85.

    Article  CAS  PubMed  Google Scholar 

  7. Martinez JS, Kohler PF. Variant “Goodpasture’s syndrome”? The need for immunologic criteria in rapidly progressive glomerulonephritis and hemorrhagic pneumonitis. Ann Intern Med. 1971;75(1):67–76.

    Article  CAS  PubMed  Google Scholar 

  8. Whitworth JA, Morel-Maroger L, Mignon F, Richet G. The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron. 1976;16(1):1–19.

    Article  CAS  PubMed  Google Scholar 

  9. Stilmant MM, Bolton WK, Sturgill BC, Schmitt GW, Couser WG. Crescentic glomerulonephritis without immune deposits: clinicopathologic features. Kidney Int. 1979;15(2):184–95.

    Article  CAS  PubMed  Google Scholar 

  10. Cunningham 3rd RJ, Gilfoil M, Cavallo T, Brouhard BH, Travis LB, Berger M, et al. Rapidly progressive glomerulonephritis in children: a report of thirteen cases and a review of the literature. Pediatr Res. 1980;14(2):128–32.

    Article  PubMed  Google Scholar 

  11. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed). 1982;285(6342):606.

    Article  CAS  Google Scholar 

  12. Croker BP, Lee T, Gunnells JC. Clinical and pathologic features of polyarteritis nodosa and its renal-limited variant: primary crescentic and necrotizing glomerulonephritis. Hum Pathol. 1987;18(1):38–44.

    Article  CAS  PubMed  Google Scholar 

  13. Chen KT. Renal-limited polyarteritis nodosa. Hum Pathol. 1987;18(10):1074–5.

    Article  CAS  PubMed  Google Scholar 

  14. Jennette JC, Falk RJ. The pathology of vasculitis involving the kidney. Am J Kidney Dis. 1994;24(1):130–41.

    Article  CAS  PubMed  Google Scholar 

  15. Feehally J, Wheeler DC, Wallis J, Jones S, Lockwood CM, Savage CO. A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol. 1987;27(4):214–5.

    CAS  PubMed  Google Scholar 

  16. Walters MD, Savage CO, Dillon MJ, Lockwood CM, Barratt TM. Antineutrophil cytoplasm antibody in crescentic glomerulonephritis. Arch Dis Child. 1988;63(7):814–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988;318(25):1651–7.

    Article  CAS  PubMed  Google Scholar 

  18. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CG, et al. Wegener’s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 1989;84(5):1577–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Charles LA, Falk RJ, Jennette JC. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol. 1989;53(2 Pt 1):243–53.

    Article  CAS  PubMed  Google Scholar 

  20. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):23–32.

    CAS  PubMed  Google Scholar 

  21. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61(1):80–9.

    Article  PubMed  Google Scholar 

  22. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis. 2003;41(3):539–49.

    Article  PubMed  Google Scholar 

  23. Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65(6):2145–52.

    Article  CAS  PubMed  Google Scholar 

  24. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  25. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628–36.

    Article  PubMed  Google Scholar 

  26. Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476–85.

    Article  CAS  PubMed  Google Scholar 

  27. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8(2):314–22.

    CAS  PubMed  Google Scholar 

  28. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–41.

    Article  CAS  PubMed  Google Scholar 

  29. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990;87(11):4115–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol. 1991;50(6):539–46.

    CAS  PubMed  Google Scholar 

  31. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 1992;41(2):375–83.

    Article  CAS  PubMed  Google Scholar 

  32. Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin Exp Immunol. 1997;108(2):234–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Rarok AA, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol. 2003;74(1):3–15.

    Article  CAS  PubMed  Google Scholar 

  34. Schreiber A, Pham CT, Hu Y, Schneider W, Luft FC, Kettritz R. Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis. J Am Soc Nephrol. 2012;23(3):470–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis. 2005;45(4):758–61.

    Article  PubMed  Google Scholar 

  36. van Paassen P, Tervaert JW, Heeringa P. Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis? Nephron Exp Nephrol. 2007;105(1):e10–6.

    Article  PubMed  Google Scholar 

  37. Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, et al. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med. 1995;181(2):585–97.

    Article  CAS  PubMed  Google Scholar 

  38. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14(10):1088–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kain R, Tadema H, McKinney EF, Benharkou A, Brandes R, Peschel A, et al. High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J Am Soc Nephrol. 2012;23(3):556–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.

    Article  CAS  PubMed  Google Scholar 

  41. Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Knight A, Sandin S, Askling J. Risks and relative risks of Wegener’s granulomatosis among close relatives of patients with the disease. Arthritis Rheum. 2008;58(1):302–7.

    Article  PubMed  Google Scholar 

  43. Willcocks LC, Lyons PA, Rees AJ, Smith KG. The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis. Arthritis Res Ther. 2010;12(1):202.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Heckmann M, Holle JU, Arning L, Knaup S, Hellmich B, Nothnagel M, et al. The Wegener’s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis. 2008;67(7):972–9.

    Article  CAS  PubMed  Google Scholar 

  45. Audrain MA, Sesboüé R, Baranger TA, Elliott J, Testa A, Martin JP, et al. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. Nephrol Dial Transplant. 2001;16(1):39–44.

    Article  CAS  PubMed  Google Scholar 

  46. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. McCormic RV. Periarteritis occurring during propylthyourasil treatment. JAMA. 1950;144(17):1453–4.

    Article  Google Scholar 

  48. Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993;342(8872):651–2.

    Article  CAS  PubMed  Google Scholar 

  49. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124(6):986–8.

    Article  CAS  PubMed  Google Scholar 

  50. Fujieda M, Hattori M, Kurayama H, Koitabashi Y, Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol. 2002;13(2):437–45.

    CAS  PubMed  Google Scholar 

  51. Wang C, Gou SJ, Xu PC, Zhao MH, Chen M. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Res Ther. 2013;15(6):R196.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;49(5):607–14.

    Article  CAS  PubMed  Google Scholar 

  53. Hogan SL, Cooper GS, Savitz DA, Nylander-French LA, Parks CG, Chin H, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol. 2007;2(2):290–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994;120(1):12–7.

    Article  CAS  PubMed  Google Scholar 

  55. Gendelman S, Zeft A, Spalding SJ. Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort. J Rheumatol. 2013;40(6):929–35.

    Article  CAS  PubMed  Google Scholar 

  56. Vanoni F, Bettinelli A, Keller F, Bianchetti MG, Simonetti GD. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatr Nephrol. 2010;25(2):205–12.

    Article  PubMed  Google Scholar 

  57. Hattori M, Kurayama H, Koitabashi Y, Japanese Society for Pediatric Nephrology. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol. 2001;12(7):1493–500.

    CAS  PubMed  Google Scholar 

  58. Eleftheriou D, Dillon MJ, Brogan PA. Advances in childhood vasculitis. Curr Opin Rheumatol. 2009;21(4):411–8.

    Article  PubMed  Google Scholar 

  59. Tullus K, Marks SD. Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment. Paediatr Drugs. 2009;11(6):375–80.

    Article  PubMed  Google Scholar 

  60. Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines – application to the individual patient. Kidney Int. 2012;82(8):840–56.

    Article  PubMed  Google Scholar 

  61. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniex, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44.

    Article  CAS  PubMed  Google Scholar 

  62. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):33–9.

    CAS  PubMed  Google Scholar 

  63. Yu F, Huang JP, Zou WZ, Zhao MH. The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children. Pediatr Nephrol. 2006;21(4):497–502.

    Article  PubMed  Google Scholar 

  64. Siomou E, Tramma D, Bowen C, Milford DV. ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome. Pediatr Nephrol. 2012;27(10):1911–20.

    Article  PubMed  Google Scholar 

  65. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180–8.

    Article  CAS  PubMed  Google Scholar 

  66. de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150(10):670–80.

    Article  PubMed  Google Scholar 

  67. Walters GD, Willis NS, Craig JC. Interventions for renal vasculitis in adults. A systematic review. BMC Nephrol. 2010;11:12.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Jones RB, Tervaert JW, Hauser T, Lugmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363(3):211–20.

    Article  CAS  PubMed  Google Scholar 

  69. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med. 2013;369(5):417–27.

    Article  CAS  PubMed  Google Scholar 

  71. Glöckner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, et al. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Clin Nephrol. 1988;29(1):1–8.

    PubMed  Google Scholar 

  72. Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis. 1992;20(3):261–9.

    Article  CAS  PubMed  Google Scholar 

  73. Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, et al. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis. 2011;57(4):566–74.

    Article  PubMed  Google Scholar 

  74. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener’s granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol. 1998;9(5):842–52.

    CAS  PubMed  Google Scholar 

  75. Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA. 2010;304(21):2381–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shori Takahashi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Takahashi, S., Nagata, M., Saito, H. (2016). Renal Vasculitis in Children. In: Geary, D., Schaefer, F. (eds) Pediatric Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52972-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-52972-0_27

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-52970-6

  • Online ISBN: 978-3-662-52972-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics